Articles > insulin

Executives of the Big Three pharma companies involved in diabetes research, development, and manufacturing — Eli Lilly and Co., Novo Nordisk, and Sanofi — spoke publicly this week at JPMorgan’s 2020 Healthcare conference on issues related to insulin pricing and supply.

Fiasp fast acting insulin pen

The U.S. Food and Drug Administration has approved Novo Nordisk's fast-acting Fiasp insulin for use in children as well as adults, the pharmaceutical firm announced Monday.

A patient loads insulin for his routine shot.

At least 17 states have passed laws carving out exceptions for pharmacists to fill insulin prescriptions during emergency situations. These legal reforms are seen by some advocates as the first real sign of progress for improved access to insulin in the United States.

logo for French pharma manufacturer Sanofi

Sanofi, the French pharmaceutical giant which manufactures the long-acting insulin Lantus, announced Monday that it would no longer be investing in research for new drugs to treat diabetes. The manufacturer also told investors it would no longer be investigating new treatments for cardiovascular health. “To be out of cardiovascular and diabetes is not easy for …

Insulin Singled Out in Ambitious Bill By House Democrats to Lower Drug Prices

The bill would mandate that the government negotiate with drug makers about the price of insulin, both in the Medicare program and for the open insurance market. It also includes many other mechanisms intended to lower the price of insulin and other drugs.

ere are Six Recent Moves to Curb Co-Pay Costs for Insulin

Four insurers have introduced a cap on monthly insulin costs, but the federal government’s move to change regulations around high-deductible insurance plans may have the biggest long-term impact.

The company also will offer a $99 monthly subscription for up to three vials or two packs of any combination of Novo Nordisk’s analog insulins.

Insulin Pumps for Beginners

Insulin Pumps for Beginners

An overview of insulin pump therapy, with Diabetes Care and Education Specialist Ashlee Ernst.

Fiasp Approved for Children with Type 1 Diabetes in Europe

Novo Nordisk, the makers of Fiasp, has also asked the FDA to approve pediatric use of the insulin.

Preprandial Insulin and Routine Eating Patterns May Help Children with Type 1 Diabetes Reach Glycemic Targets

In the Australian study, researchers found that regular mealtimes and less snacking was associated with lower HbA1c.